top of page

Welcome to Forethought India One-on-One Courses. Our program is designed to provide students with the skills and knowledge necessary to excel in their chosen profession. Our instructor for this course is Professor Ian Goodfellow at University of Cambridge.



"Healing Horizons: Biopharmaceuticals and Medical Marvels" is an immersive and dynamic course designed to explore the cutting-edge realm of biopharmaceuticals and groundbreaking medical innovations. Spanning over a series of meticulously crafted lectures, this course delves into the intricate world of biopharmaceutical development, emphasizing its pivotal role in revolutionizing modern healthcare. Participants will navigate through a spectrum of topics, ranging from the foundational understanding of biopharmaceuticals and medical marvels to the advanced nuances of drug development, clinical trials, and ethical considerations. Additionally, the course extends its gaze to the forefront of medical advancements, illuminating areas such as precision medicine, gene therapy, immunotherapy, nanotechnology in medicine, regenerative techniques, and AI's impact on drug discovery. Emphasizing the fusion of technology, ethics, and scientific progress, this course offers a comprehensive exploration into the promising landscape of biopharmaceuticals, addressing the challenges, innovations, and future possibilities in the field, inviting learners into the realm of transformative healthcare solutions.


At the end of the program, students will receive a certificate & performance letter by the educator indicating that they have completed the program and acquired the necessary skills and knowledge to excel in their chosen profession.

Healing Horizons: Biopharmaceuticals and Medical Marvels, by Ian Goodfellow

  • Ian Goodfellow is Professor of Virology and Deputy Head of Department (Pathology). His research focuses on the mechanisms of RNA virus replication and pathogenesis as well as the identification of control measures for the prevention or treatment of infections. His lab established the use of reverse genetics to study the molecular basis of norovirus pathogenesis, developing the first infectious reverse genetics system for noroviruses and the study of no viruses remains their main focus. During the 2014-16 Ebola virus epidemic, Professor Goodfellow was involved in the establishment and running of one of the first diagnostic facilities in Sierra Leone before subsequently returning to establish an in-country next generation sequencing facility to enable rapid sequence analysis of Ebola viral samples. Professor Goodfellow now holds an honorary position at the University of Makeni, Sierra Leone where he has established a research facility for post-Ebola capacity building.

bottom of page